Michael P. Stansky - 23 Feb 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Mary Szela, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
23 Feb 2026
Net transactions value
+$1,480,502
Form type
4
Filing time
23 Feb 2026, 16:08:00 UTC
Previous filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stansky Michael P Director 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 23 Feb 2026 0001424204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Purchase $999,990 +243,900 +45% $4.10 787,132 23 Feb 2026 Direct
transaction TLSI Common Stock Purchase $480,512 +117,198 +142% $4.10 199,698 23 Feb 2026 By LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.